drugset / Trial / NCT03824665

Nalbuphine, Fentanyl and no Additive to Local Anaesthetic Mixture

NCT03824665

Phase 4 Completed 120 enrolled Cairo University
RandomizedParallel-groupDouble-blindSupportive care

Summary

Nalbuphine has been used as an adjuvant to bupivacaine in intrathecal,epidural, caudal anesthesia and peripheral nerve blocks showing an increase in the efficacy and the duration of postoperative analgesia. The aim of this study is evaluation of the effect of 4 mg Nalbuphine when used as an adjuvant to a local anesthetic mixture in peribulbar block undergoing posterior chamber surgery in adult patients and comparing it with adding Fentanyl 20 μg to LAM and LAM alone

Timeline

Start
2019-02-05
Primary completion
2019-05-10
Completion
2019-05-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 20 ug Other
Comparator Nalbuphine Small molecule 4 mg Other
Background Bupivacaine Other / unclassified 0.5 % Other
Background Bupivacaine Other / unclassified 6 ml Other
Background rHuPH20 Protein / enzyme biologic 150 iu Other

Indications

No indication recorded.